NYSE Arca · FBT

First Trust NYSE Arca Biotechnology Index Fund (FBT)

$273.36+0.18%
Close Sep 28, 2026 · split-adjusted
Sep 28, 2026$273.36▲ 54.59% in range
Sep 29, 2025Low $176.83 · High $273.91Sep 28, 2026
What changed · written from our data
As of Sep 28, 2026

First Trust NYSE Arca Biotechnology Index Fund closed at $273.36 on Sep 28, up 0.18%, 0.2% below its 52-week closing high. Volume of 99.8K shares was 1.42× its 20-day average (above normal).

Split-adjusted performance: -0.2% over one month, +43.7% over six months, +57.0% over one year.

Short interest was 45.1K shares at the Sep 15 settlement, up 81.5% from the prior report (1.6 days to cover).

Market cap$2.98B10.9M shares
Revenue · quarter——
Diluted EPS——
P/E · TTM—
Net margin—
Dividend yieldNone$1.1726 last paid
52-week range174.06 – 273.91−0.2% from high
Volume99.8K1.42× 20-day avg
Volatility · 60d20.8%Annualised
Short % of float—1.6 days to cover
Net cash—
Next earnings—Not scheduled
Split-adjusted performance
1W +1.3%1M −0.2%3M +10.4%6M +43.7%YTD +32.4%1Y +57.0%3Y +86.4%5Y +59.6%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within industry

Not enough peers to rank

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Short interest

Details →
Shares short45.1K+81.5% vs prior
Days to cover1.6Settled Sep 15
% of float—
Short vol. 10d55.9%of daily volume

Quick answers

What is FBT's market cap?
$2.98B, based on the Sep 28 close of $273.36.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology